AAIPharma appoints Patrick Walsh

pharmafile | September 21, 2010 | Appointment | Manufacturing and Production AAIPharma, appointment, manufacturing and production 

Contract manufacturing and drug development services company AAIPharma has appointed Patrick Walsh as its new chief executive.

Walsh has 30 years of pharmaceutical manufacturing experience and joins the company after stints at Kadmus Pharmaceuticals and Gensia Sicor.

Pete Strothman, a principal with Water Street and a member of AAIPharma Services’ board of directors, said: “Pat has an impressive record of consistently leading pharmaceutical businesses to achieve high levels of growth over the course of his career. He is the ideal executive to advance AAIPharma Services forward, as we focus on pursuing growth opportunities through a combination of organic initiatives and strategic acquisitions.

Pat’s core skills of business development, relationship-building, and sales and marketing will contribute significantly to AAIPharma and our goal of building it into the leading provider of pharmaceutical development services.”

Lee Karras, the firm’s president, who led the firm during the search for a new chief executive, will remain in that role and also becomes chief operating officer.

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content